View in EDS

Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.

Saved in:
Bibliographic Details
Title: Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
Authors: Palomero J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Panisello C; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Lozano-Rabella M; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Tirtakasuma R; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Díaz-Gómez J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Grases D; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Pasamar H; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Arregui L; HUB-ICO-IDIBELL Biobank, Bellvitge Institute for Biomedical Research, L'Hospitalet de Llobregat, Spain., Dorca Duch E; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain., Guerra Fernández E; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain., Vivancos A; Cancer Genomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., de Andrea CE; Pathology, Clinica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain., Melero I; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research IDISNA, Pamplona, Spain., Ponce J; Department of Gynaecology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain., Vidal A; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain., Piulats JM; Medical Oncology, Catalan Institute of Oncology (ICO), IDIBELL-OncoBell, L'Hospitalet de Llobregat, Spain., Matias-Guiu X; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology, Arnau de Vilanova University Hospital, University of LLeida, IRBLLEIDA, Lleida, Spain., Gros A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain agros@vhio.net.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36581331
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Biomarkers of tumor-reactive CD4<superscript>+</superscript> and CD8<superscript>+</superscript> TILs associate with improved prognosis in endometrial cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Palomero+J%22">Palomero J</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Panisello+C%22">Panisello C</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lozano-Rabella+M%22">Lozano-Rabella M</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tirtakasuma+R%22">Tirtakasuma R</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Díaz-Gómez+J%22">Díaz-Gómez J</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Grases+D%22">Grases D</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pasamar+H%22">Pasamar H</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arregui+L%22">Arregui L</searchLink>; HUB-ICO-IDIBELL Biobank, Bellvitge Institute for Biomedical Research, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Dorca+Duch+E%22">Dorca Duch E</searchLink>; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Guerra+Fernández+E%22">Guerra Fernández E</searchLink>; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Vivancos+A%22">Vivancos A</searchLink>; Cancer Genomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22de+Andrea+CE%22">de Andrea CE</searchLink>; Pathology, Clinica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Melero+I%22">Melero I</searchLink>; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research IDISNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ponce+J%22">Ponce J</searchLink>; Department of Gynaecology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal+A%22">Vidal A</searchLink>; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Piulats+JM%22">Piulats JM</searchLink>; Medical Oncology, Catalan Institute of Oncology (ICO), IDIBELL-OncoBell, L'Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Matias-Guiu+X%22">Matias-Guiu X</searchLink>; Pathology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Spain.; Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology, Arnau de Vilanova University Hospital, University of LLeida, IRBLLEIDA, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Gros+A%22">Gros A</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain agros@vhio.net.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2022 Dec; Vol. 10 (12).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36581331
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2022-005443
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palomero J
      – PersonEntity:
          Name:
            NameFull: Panisello C
      – PersonEntity:
          Name:
            NameFull: Lozano-Rabella M
      – PersonEntity:
          Name:
            NameFull: Tirtakasuma R
      – PersonEntity:
          Name:
            NameFull: Díaz-Gómez J
      – PersonEntity:
          Name:
            NameFull: Grases D
      – PersonEntity:
          Name:
            NameFull: Pasamar H
      – PersonEntity:
          Name:
            NameFull: Arregui L
      – PersonEntity:
          Name:
            NameFull: Dorca Duch E
      – PersonEntity:
          Name:
            NameFull: Guerra Fernández E
      – PersonEntity:
          Name:
            NameFull: Vivancos A
      – PersonEntity:
          Name:
            NameFull: de Andrea CE
      – PersonEntity:
          Name:
            NameFull: Melero I
      – PersonEntity:
          Name:
            NameFull: Ponce J
      – PersonEntity:
          Name:
            NameFull: Vidal A
      – PersonEntity:
          Name:
            NameFull: Piulats JM
      – PersonEntity:
          Name:
            NameFull: Matias-Guiu X
      – PersonEntity:
          Name:
            NameFull: Gros A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2022 Dec
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1